PAINREFORM LTD (PRFX)
IL0011651580 - Common Stock
PainReform Announces Closing of $4 Million Public Offering
TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty...
Unusual volume stocks in Tuesday's session
Unusual volume stocks in Tuesday's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Let's have a look at the gap up and gap down stocks in today's session.
Which stocks are moving before the opening bell on Tuesday?
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
TEL AVIV, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
Remains on track to announce top-line data by mid-2024...
PainReform Provides Year-End Business Update
Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce top-line data by mid-2024 TEL...
PainReform to Present at the Microcap Conference in Atlantic City
TEL AVIV, Israel, Jan. 22, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
PainReform files to sell 968,545 ordinary shares for holders (NASDAQ:PRFX)
PainReform (PRFX) files a prospectus for resale of up to 968,545 ordinary shares, however, it is not an offer to sell.
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
PRF-110 demonstrated superior formulation properties with respect to surface-tissue spreading...
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds
TEL AVIV, Israel, Dec. 26, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
PainReform Provides Business Update for the Third Quarter of 2023
Reports enrollment of first patients for the second part of Phase 3 clinical trial in bunionectomy...
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File
Targeting to commence second part of Phase 3 clinical trial in mid-Q4 2023 Trial completion and results expected in mid-2024 TEL AVIV, Israel, Sept. 11,...
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary
Professor Eli Hazum to Share Positive Safety and PK Data of PRF-110 from First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing...
PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City
TEL AVIV, Israel, Sept. 05, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
PainReform Provides Business Update for the Second Quarter of 2023
Targeting to commence second part of Phase 3 clinical trial in bunionectomy during the fourth quarter of 2023...
7 Stocks Under $10 to Buy for August
Stocks under $10 have many advantages, so it pays to see which has the best potential for growth. The Portfolio Grader can help with that.
Why Is Discover Financial (DFS) Stock Down 13% Today?
Discover Financial (DFS) stock is falling on Thursday after the financial services company revealed it's undergoing a regulatory review.
Why Is Netcapital (NCPL) Stock Down 42% Today?
Netcapital (NCPL) stock is dropping on Thursday after the fintech company announced the pricing of a public share offering.
Why Is Eliem Therapeutics (ELYM) Stock Up 6% Today?
Eliem Therapeutics (ELYM) stock is taking off on Thursday after the biotechnology company announced plans to explore strategic alternatives.
Why Is PainReform (PRFX) Stock Up 38% Today?
PainReform (PRFX) stock is rallying on Thursday after the pharmaceutical company regained compliance with Nasdaq listing requirements.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!
PainReform regains compliance with Nasdaq's minimum bid price rule (NASDAQ:PRFX)
PainReform (PRFX) said on Wednesday that the specialty pharmaceutical company has regained compliance with Nasdaq's minimum bid price requirement.
PainReform Regains Compliance with Nasdaq Continued Listing Requirements
TEL AVIV, Israel, July 19, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement
TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today
Here's what investors should be watching with PainReform, as PRFX stock more than doubles in an incredible session today.